Abstract:On the basis of biphenylaminoquinoline scaffold, we investigated structure–activity relationship analysis on the meta or para position of biphenyl ring. 7j displayed the most potent cytotoxicity against these four cancer cells, SW480, DU145, MDA‐MB‐231, and MiaPaCa‐2, with IC50 values of 1.05, 0.98, 0.38, and 0.17 μM, respectively. The biphenyl scaffold represents a prominent privileged structure within the realms of organic chemistry and drug development. Biphenyl derivatives have demonstrated notable biological activities, including antimicrobial, anti‐inflammatory, anti‐HIV, and the treatment of neuropathic pain. Importantly, their anticancer abilities should not be underestimated. In this context, the present study involves the design and synthesis of a series of biphenyl derivatives featuring an additional privileged structure, namely the quinoline core. We have also diversified the substituents attached to the benzyloxy group at either the meta or para position of the biphenyl ring categorized into two distinct groups: [4,3′]biphenylaminoquinoline‐substituted and [3,3′]biphenylaminoquinoline‐substituted compounds. We embarked on an assessment of the cytotoxic activities of these derivatives in colorectal cancer cell line SW480 and prostate cancer cell line DU145 for exploring the structure–activity relationship. Furthermore, we determined the IC50 values of selected compounds that exhibited superior inhibitory effects on cell viability against SW480, DU145 cells, as well as MDA‐MB‐231 and MiaPaCa‐2 cells. Notably, [3,3′]biphenylaminoquinoline derivative 7j displayed the most potent cytotoxicity against these four cancer cell lines, SW480, DU145, MDA‐MB‐231, and MiaPaCa‐2, with IC50 values of 1.05 μM, 0.98 μM, 0.38 μM, and 0.17 μM, respectively. This highly promising outcome underscores the potential of [3,3′]biphenylaminoquinoline 7j for further investigation as a prospective anticancer agent in future research endeavors.

Structure–activity relationship studies of 5,7-dihydroxyflavones as naturally occurring inhibitors of cell proliferation in human leukemia HL-60 cells

Studies of the Synthesis and the Structure-activity Relationship of 3-Methylflavones

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Prenylflavonoids as nonsteroidal phytoestrogens and related structure-activity relationships.

Natural and Synthetic Flavonoids: Structure–Activity Relationship and Chemotherapeutic Potential for the Treatment of Leukemia

Design, Synthesis and Biological Evaluation of 3-Benzylideneflavanone Derivatives As Cytotoxic Agents

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Antiproliferative Activity of Flavonoids: Influence of the Sequential Methoxylation State of the Flavonoid Structure

Synthesis and antiproliferative activities of polymethoxyflavones aminoalkyl and amino acid derivatives

Relationship between Antioxidant and Anticancer Activity of Trihydroxyflavones

Design, synthesis and anticancer activity of novel steroidal derivatives with D‐ring fused or substituted N‐heterocyclic systems

Comparative Analysis of Acetylated Flavonoids' Chemopreventive Effects in Different Cancer Cell Lines

Synthesis of Flavonols and Assessment of Their Biological Activity as Anticancer Agents

Synthesis and structure-activity relationships of N-methyl-5,6,7-trimethoxylindoles as novel antimitotic and vascular disrupting agents.

Synthesis and Antiproliferative Activity of Natural and Non-Natural Polymethoxychalcones and Polymethoxyflavones

Synthesis and Cytotoxic Evaluation of Novel 7‐o‐modified Genistein Derivatives

[The Anti-Leukemia Effect of Sophora Flavescens and Its Mechanism].

Synthesis, Anticancer Activity, Structure-Activity Relationship and Mechanistic Investigations of Falcarindiol Analogues

Synthesis and biological evaluation of the novel antitumor agent 3'-monosubstituted chalcone derivatives

Design, Synthesis and 3D-QSAR Study of Cytotoxic Flavonoid Derivatives.

Synthesis and SAR investigation of biphenylaminoquinoline derivatives with benzyloxy substituents as promising anticancer agents